Ubs Asset Management Americas Inc Athersys, Inc Transaction History

Ubs Asset Management Americas Inc

  • $381 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
BUY
$1.41 - $1.94 $20,078 - $27,625
14,240 Added 10.3%
152,508 $219,000
Q4 2020

Mar 01, 2021
SELL
$1.55 - $2.24 $6,852 - $9,903
-4,421 Reduced 3.1%
138,268 $241,000
Q2 2020

Aug 14, 2020
BUY
$1.97 - $3.98 $281,097 - $567,902
142,689 New
142,689 $393,000

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email